Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Drug Discovery & Development

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

BTIG Initiates Coverage of NeoGenomics With Buy Rating

BTIG highlighted the firm's cancer test portfolio, as well as its growing position in the liquid biopsy and minimal residual disease testing space.

PMC Report Outlines Strong Growth, Future Challenges for Personalized Medicine Industry

Premium

As adoption of personalized medicines has accelerated over the last four years, so has the number of marketed genetic and exome tests.

Freenome Maintains CRC Early Detection Timeline as New Biomarker Discovery Studies Progress

Premium

The company is using newly raised funds to support a disseminated trial model, which it said will help it keep its plans to finish the study by the end of 2021.

Senate Republicans Propose $36B for HHS Coronavirus Testing, Drug Development

The funding package earmarks billions for the Public Health and Social Services Emergency Fund and Biomedical Advanced Research and Development Authority.

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

Caris will sequence DNA and RNA for certain cancer patients and potentially help Merus enroll cancer patients with NRG1 fusions in the Phase I/II eNRGy trial for zenocutuzumab.

Jun 18, 2020

FDA Approves Epizyme's Tazverik, Roche CDx for EZH2-Mutated Follicular Lymphoma Patients

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium
Apr 15, 2020

Axovant, Invitae Launch Free Genetic Testing Program for Lysosomal Storage Diseases

Feb 20, 2020

FDA Releases List of Evidence-Based PGx Variants

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Dec 04, 2019

PGDx Gets IDE For Tissue NGS Test in Merck Immunotherapy Trial

Nov 27, 2019

HalioDx, OSE Immunotherapeutics Collaborate on Immune Biomarkers for NSCLC Treatment

Nov 19, 2019

HalioDx, Kite Pharma Extend Biomarker Collaboration

Nov 18, 2019

Centogene to Provide Diagnostic Testing Services for PTC Therapeutics Gene Therapy Program

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Nov 07, 2019

Centogene Prices US IPO at $14 per Share

Oct 17, 2019

Centogene Files to Go Public in US

Oct 10, 2019

FDA Issues Final Guidance on IVD Reviews for Investigational Cancer Drug Trials

Oct 10, 2019

UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case

Aug 16, 2019

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Aug 13, 2019

Adaptive Biotechnologies Q2 Revenues Rise 91 Percent

Jul 24, 2019

Gray Foundation Awards $25M in Cancer Research Grants

Jun 24, 2019

SpeeDx, GSK Sign Test Supply, Development Deal

May 07, 2019

Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug

Apr 24, 2019

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

More articles
May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.